Will Healy

Will Healy

Will Healy is a freelance financial writer. He had a lifelong interest in the stock market, trading equities since the dot-com boom. Will pursued his passion for writing after working in the corporate world as both an analyst and an insurance sales professional. He likes to approach the market by focusing on deep value, dividends, and speculation.

Will’s writing has focused on stock analysis, as well as real estate, insurance, personal finance, macroeconomics, and politics. Along with InvestorPlace, his work has appeared on numerous sites, including Seeking Alpha, Yahoo! Finance, MSN Money, Kiplinger Tax Letter, and GOBankingRates. He holds both a B.S. in Journalism and an MBA in finance and strategy.

Recent Articles

Twilio Stock Could Be Hurt by Increased Competition

Twilio stock and Twilio Inc both face increasing competition that could cause both investors and customers to question their ties to the firm.

Amazon Stock Will Probably Test $1,500 but It Wan’t Fall Below It

Tariff issues and an antitrust probe could take Amazon stock to the lower end of its range, but that should also create a buying opportunity.

Is Lululemon Stock Too Risky to Bet On Before Earnings?

The long-term outlook for Lululemon looks bright, but an anticipated earnings beat may not translate into short-term gains for LULU stock.

Aphria Stock Could Deliver Massive Gains

APHA plunged last year on analyst downgrades, but a new management team and strategic initiatives could spark a recovery for Aphria stock.

3 Software Stocks to Buy for Big Changes And High Growth

These three software stocks trade at lower valuations and show high growth potential, but more importantly, they're showing their ability to change with the times.

Investors Aren’t Likely to Clean up on Procter & Gamble Stock

Procter & Gamble stock should remain steady, but the higher multiple and the recent surge higher leaves little room for near-term growth.

Tesla Stock Trades on Sales, Not Greenhouse Gases

The recent revelation eliminates a minor concern about Tesla's revenue but will have little influence over the direction of Tesla stock.

FDA Hearing Won’t Hurt Canopy’s Growth, But It Could Hit CGC Stock

Although mixed news from the FDA hearing will probably not hurt Canopy Growth, it could lead to questions about the valuation of CGC stock.

5G Very Well May Be the Saving Grace for CenturyLink Stock

CTL stock has suffered for years from cord-cutting, but an emerging tech trend that many thought would destroy CTL could actually save it.

Samsung Deal Could Help AMD Stock Past the $34 Per Share Level

Thanks to the Samsung deal and the competitive and earnings strides made in recent years, AMD stock can surge past multi-year highs.